Affordable Access

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.

Authors
Type
Published Article
Journal
Epidemiology
1044-3983
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
17
Issue
6
Pages
701–704
Identifiers
PMID: 17028507
Source
Medline
License
Unknown

Abstract

We found an increased risk of congenital malformations after exposure to SSRIs in early pregnancy. It is unclear whether the effects were causal or due to factors related to the underlying disease. There was no evidence that the association was specific to particular malformations.

Statistics

Seen <100 times